BP Lipid 306 is an ionizable lipid with an butanolamine amino lipid head, enhancing encapsulation of mRNA. The lipid has primary esters at C8 position relative to the amine nitrogen. The lipid tails each have 8 carbons. The lipid can be used for mRNA-based therapies which depends on the availability of a safe and efficient delivery vehicle. Reagent grade, for research purpose.
Usually ships within 24 hours.